Comparing Sleep Compression Therapy and Sleep Restriction Paradigms

Chronic insomnia disorder represents a pervasive public health challenge that significantly degrades psychological wellbeing and metabolic health. Cognitive behavioral therapy for insomnia remains the recognized first-line intervention across international clinical guidelines. Within this behavioral framework, sleep restriction therapy serves as an indispensable and highly effective component. However, this established technique frequently causes acute daytime sleepiness, irritability, and cognitive fatigue during initial implementation. Consequently, clinicians often encounter patient resistance, treatment anxiety, or early attrition. To address these compliance hurdles, sleep compression therapy emerged as a potentially gentler behavioral alternative. Rather than abruptly restricting time in bed to total sleep duration, compression steadily curtails bed rest over several weeks. Therefore, patients experience a more gradual sleep consolidation process. Historically, clinicians lacked head-to-head randomized trial evidence comparing these two behavioral paradigms directly. Practitioners frequently debated whether the gentler trajectory of compression sacrificed clinical efficacy. The landmark CompRest trial resolved this fundamental question through a direct, randomized investigation. Specifically, researchers evaluated whether gradual compression could match the therapeutic potency of abrupt restriction. Moreover, this pivotal investigation provided empirical clarity regarding subjective recovery rates and adverse event profiles.

Methodological Rigor and Design of the CompRest Trial

To rigorously evaluate both behavioral modalities, investigators launched the single-blind CompRest trial at the Internet Psychiatry Clinic in Stockholm. Researchers recruited 234 adult patients who met strict diagnostic criteria for persistent insomnia disorder. Notably, the study cohort presented with a mean age of 44.3 years, and 73.4% of participants were female. Investigators randomized participants equally in a 1:1 ratio to receive either sleep compression therapy or sleep restriction therapy. Both intervention arms completed a 10-week, highly structured, therapist-guided digital program. This digital delivery model ensured consistent experimental fidelity, standardized therapeutic exposure, and close clinical monitoring. Clinicians tracked patient progress weekly using online sleep logs and standardized psychometric instruments. Specifically, the primary clinical endpoint was the change in self-reported Insomnia Severity Index scores assessed through week 10. Investigators established a conservative non-inferiority margin of 1.6 points on this validated index. Furthermore, the statistical protocol utilized intent-to-treat analyses incorporating multiple imputation and linear mixed-effects models. This robust design ensured that patient dropouts did not introduce bias into the comparative results. Consequently, the trial generated exceptionally reliable clinical evidence for behavioral sleep medicine.

Primary Clinical Efficacy and Non-Inferiority Trial Findings

The trial demonstrated that both behavioral interventions produced substantial and clinically meaningful reductions in insomnia severity. However, sleep compression therapy failed to demonstrate non-inferiority when compared directly against classic sleep restriction therapy. The primary statistical analysis revealed a 95% confidence interval ranging from -0.01 to 1.70 points. Because the upper confidence limit exceeded the predefined 1.6-point margin, non-inferiority could not be established statistically. Furthermore, sleep restriction generated statistically significantly greater overall improvements in insomnia scores than gradual compression (p = .006). Beyond total symptom reduction, the rate of clinical recovery differed substantially between the two therapeutic arms. Patients assigned to restriction experienced rapid symptom relief within the earliest weeks of treatment. In contrast, participants undergoing compression demonstrated a noticeably slower recovery trajectory across the 10-week protocol. Therefore, while compression consolidates sleep, it does not match the rapid potency of abrupt bedtime restriction. These findings provide unambiguous evidence that sleep restriction delivers superior therapeutic efficacy for chronic insomnia disorder. Clinicians must consider these differing timelines when discussing behavioral expectations with their patients. Additionally, these results reinforce sleep restriction as the premier behavioral intervention.

Tolerability, Adherence Patterns, and Clinical Trade-Offs

Although sleep restriction achieved superior symptom reduction, the trial identified clear advantages for sleep compression therapy regarding tolerability. Specifically, patients in the compression cohort demonstrated significantly higher treatment adherence throughout the 10-week schedule. Because compression curtails bedtime gradually, individuals rarely experienced the jarring sleep deprivation that often characterizes abrupt restriction. Consequently, participants in the compression arm experienced fewer acute adverse effects. These included reduced rates of extreme daytime sleepiness, morning headaches, and severe cognitive fatigue during initial weeks. In contrast, abrupt restriction generated greater initial distress, which frequently discourages sensitive patients from continuing therapy. Interestingly, despite these divergence patterns in side effects and adherence, broader subjective outcomes remained remarkably comparable. Both groups demonstrated similar levels of overall treatment satisfaction upon program completion. Additionally, improvements in general daytime functioning and quality of life reached parity between both cohorts. Thus, clinicians observe a classic clinical trade-off between rapid therapeutic speed and personal intervention comfort. When patients cannot tolerate abrupt deprivation, gradual compression offers a structured, sustainable alternative that minimizes treatment dropout. Therefore, clinicians must assess patient tolerance carefully before selecting a specific behavioral intervention.

Translating Findings into Clinical Decision-Making

These rigorous trial findings carry direct practical implications for general practitioners and physicians managing chronic insomnia disorder. Clinical guidelines universally recommend cognitive behavioral techniques as first-line therapy before initiating sedative-hypnotic medications. Based on this randomized trial, healthcare providers should continue prioritizing sleep restriction therapy as their primary behavioral strategy. It delivers significantly faster symptom control and produces superior symptom resolution for the vast majority of patients. Nevertheless, clinicians must recognize that one behavioral approach does not fit every patient profile. Sleep compression therapy serves as an indispensable alternative for specific vulnerable populations. For example, elderly patients with frailty or elevated fall risks benefit substantially from gradual bedtime reduction. Similarly, individuals with comorbid bipolar disorder or severe panic disorders require gentler transitions to prevent symptom destabilization. In such sensitive cases, gradual compression provides a safer, highly acceptable pathway to consolidate nocturnal sleep. Furthermore, clinicians can utilize digital health tools and mobile applications to deliver these structured protocols effectively. Healthcare professionals should therefore tailor time-in-bed recommendations to individual patient risk profiles and tolerance levels. This personalized approach optimizes clinical compliance while ensuring robust, sustained therapeutic improvements.

What is the difference between sleep restriction and sleep compression?

Sleep restriction therapy immediately curtails time spent in bed to match the patient's actual total sleep time. In contrast, sleep compression therapy gradually reduces time in bed in weekly increments over several weeks. Consequently, compression provides a gentler, more gradual sleep consolidation process with reduced initial daytime fatigue.

Why did sleep compression fail to achieve non-inferiority in the trial?

Sleep compression therapy produced statistically smaller improvements on the Insomnia Severity Index than sleep restriction therapy. Furthermore, the upper limit of the confidence interval exceeded the predefined 1.6-point non-inferiority margin. Compression also produced a significantly slower therapeutic response, meaning patients required more time to achieve symptom relief.

When should clinicians prefer sleep compression therapy over sleep restriction?

Clinicians should prefer sleep compression therapy for patients who cannot tolerate sudden sleep deprivation. This includes frail elderly individuals at risk of falls, patients with bipolar disorder vulnerable to mania, and individuals operating heavy machinery. Compression improves adherence and causes fewer adverse effects while still achieving meaningful sleep improvements.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Healthcare professionals should rely on their clinical judgment and verify details independently. Refer to the latest local and national guidelines for clinical practice.

References

1. Jernelöv S et al. Is sleep compression therapy non-inferior to sleep restriction therapy? A single-blind randomized controlled non-inferiority trial comparing sleep compression therapy to sleep restriction therapy as treatment for insomnia. Sleep. 2025 Aug 14. doi: 10.1093/sleep/zsaf093. PMID: 40205789.


2. Lichstein KL, Riedel BW, Wilson NM, Lester KW, Aguillard RN. Relaxation and sleep compression for late-life insomnia: a placebo-controlled trial. J Consult Clin Psychol. 2001;69(2):227-239.


3. Maurer LF et al. The noninferiority complex: abrupt versus gradual restriction of time in bed for insomnia disorder. Sleep. 2025;48(8):zsaf112. doi: 10.1093/sleep/zsaf112.